Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.24 MXN
2.14 B MXN
18.61 B MXN
670.36 M
About GENOMMA LAB INTERNACIONAL SAB
Sector
Industry
CEO
Marco Sparvieri
Website
Headquarters
Mexico City
Founded
1996
ISIN
MX01LA010006
FIGI
BBG000G12N97
Genomma Lab Internacional SAB de CV engages in the development, manufacturing and marketing of pharmaceutical, beauty and personal care products. The company was founded by Rodrigo Alonso Herrera Aspra on October 30, 1996 and is headquartered in Mexico City, Mexico.
Expecting a 50% return This is one of the favorites for this year for analysts. The overall recommendation is to buy and in this technical analysis we can see that the price is approaching a medium level support horizontal line that coincides with the 61% fib. My recommendation is to wait till the price hits the lower poi
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of LAB/B is 25.37 MXN — it has increased by 0.88% in the past 24 hours. Watch GENOMMA LAB INTERNACIONAL SAB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange GENOMMA LAB INTERNACIONAL SAB stocks are traded under the ticker LAB/B.
LAB/B stock has risen by 1.28% compared to the previous week, the month change is a −2.46% fall, over the last year GENOMMA LAB INTERNACIONAL SAB has showed a 64.63% increase.
We've gathered analysts' opinions on GENOMMA LAB INTERNACIONAL SAB future price: according to them, LAB/B price has a max estimate of 33.00 MXN and a min estimate of 27.00 MXN. Watch LAB/B chart and read a more detailed GENOMMA LAB INTERNACIONAL SAB stock forecast: see what analysts think of GENOMMA LAB INTERNACIONAL SAB and suggest that you do with its stocks.
LAB/B reached its all-time high on Dec 2, 2013 with the price of 40.07 MXN, and its all-time low was 3.25 MXN and was reached on Mar 17, 2009. View more price dynamics on LAB/B chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LAB/B stock is 2.20% volatile and has beta coefficient of 0.94. Track GENOMMA LAB INTERNACIONAL SAB stock price on the chart and check out the list of the most volatile stocks — is GENOMMA LAB INTERNACIONAL SAB there?
Today GENOMMA LAB INTERNACIONAL SAB has the market capitalization of 25.37 B, it has increased by 1.21% over the last week.
Yes, you can track GENOMMA LAB INTERNACIONAL SAB financials in yearly and quarterly reports right on TradingView.
GENOMMA LAB INTERNACIONAL SAB is going to release the next earnings report on Apr 30, 2025. Keep track of upcoming events with our Earnings Calendar.
LAB/B earnings for the last quarter are 0.47 MXN per share, whereas the estimation was 0.58 MXN resulting in a −19.66% surprise. The estimated earnings for the next quarter are 0.48 MXN per share. See more details about GENOMMA LAB INTERNACIONAL SAB earnings.
GENOMMA LAB INTERNACIONAL SAB revenue for the last quarter amounts to 4.67 B MXN, despite the estimated figure of 4.69 B MXN. In the next quarter, revenue is expected to reach 4.64 B MXN.
LAB/B net income for the last quarter is 473.49 M MXN, while the quarter before that showed 660.06 M MXN of net income which accounts for −28.27% change. Track more GENOMMA LAB INTERNACIONAL SAB financial stats to get the full picture.
As of Apr 3, 2025, the company has 1.6 K employees. See our rating of the largest employees — is GENOMMA LAB INTERNACIONAL SAB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENOMMA LAB INTERNACIONAL SAB EBITDA is 4.30 B MXN, and current EBITDA margin is 23.09%. See more stats in GENOMMA LAB INTERNACIONAL SAB financial statements.
Like other stocks, LAB/B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOMMA LAB INTERNACIONAL SAB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOMMA LAB INTERNACIONAL SAB technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOMMA LAB INTERNACIONAL SAB stock shows the strong buy signal. See more of GENOMMA LAB INTERNACIONAL SAB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.